Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants

PLoS Negl Trop Dis. 2009 Jun 2;3(6):e446. doi: 10.1371/journal.pntd.0000446.

Abstract

Background: Proteolytic processing of the Lassa virus envelope glycoprotein precursor GP-C by the host proprotein convertase site 1 protease (S1P) is a prerequisite for the incorporation of the subunits GP-1 and GP-2 into viral particles and, hence, essential for infectivity and virus spread. Therefore, we tested in this study the concept of using S1P as a target to block efficient virus replication.

Methodology/principal finding: We demonstrate that stable cell lines inducibly expressing S1P-adapted alpha(1)-antitrypsin variants inhibit the proteolytic maturation of GP-C. Introduction of the S1P recognition motifs RRIL and RRLL into the reactive center loop of alpha(1)-antitrypsin resulted in abrogation of GP-C processing by endogenous S1P to a similar level observed in S1P-deficient cells. Moreover, S1P-specific alpha(1)-antitrypsins significantly inhibited replication and spread of a replication-competent recombinant vesicular stomatitis virus expressing the Lassa virus glycoprotein GP as well as authentic Lassa virus. Inhibition of viral replication correlated with the ability of the different alpha(1)-antitrypsin variants to inhibit the processing of the Lassa virus glycoprotein precursor.

Conclusions/significance: Our data suggest that glycoprotein cleavage by S1P is a promising target for the development of novel anti-arenaviral strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Motifs
  • Animals
  • Antiviral Agents / metabolism*
  • Binding Sites
  • CHO Cells
  • Chlorocebus aethiops
  • Cricetinae
  • Cricetulus
  • Genetic Vectors
  • Glycoproteins / metabolism*
  • Lassa virus / physiology*
  • Proprotein Convertases / antagonists & inhibitors*
  • Protein Binding
  • Serine Endopeptidases
  • Vero Cells
  • Vesiculovirus / genetics
  • Viral Envelope Proteins / metabolism*
  • Virus Assembly / drug effects*
  • Virus Replication / drug effects
  • alpha 1-Antitrypsin / genetics
  • alpha 1-Antitrypsin / metabolism*

Substances

  • Antiviral Agents
  • Glycoproteins
  • Viral Envelope Proteins
  • alpha 1-Antitrypsin
  • Proprotein Convertases
  • Serine Endopeptidases
  • membrane-bound transcription factor peptidase, site 1